CMS is expanding coverage for remote patient monitoring in its 2026 Medicare Physician Fee Schedule, while a major payer is scaling back reimbursement to two specific use cases.
Shift verification effort from a single, time-consuming flat run to a more efficient, distributed, and scalable process.
The FDA approves a new diagnostic tool enhancing precision treatment for advanced endometrial carcinoma, improving patient outcomes with targeted therapies. The FDA has approved the OncoMate® MSI Dx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback